Parthenon Therapeutics Funding: $65M Raised, Series A (2024)
Parthenon Therapeutics is based in San Francisco, CA. It has raised $65M in total funding. Latest round: Series A.
Parthenon Therapeutics funding overview
Parthenon Therapeutics is based in San Francisco, CA. Parthenon Therapeutics has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2024. The round record for Parthenon Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Northpond Ventures, Pfizer Ventures, Taiho Ventures. 3 distinct backers are named across the disclosed rounds.
Frequently asked about Parthenon Therapeutics funding
How much has Parthenon Therapeutics raised?
Parthenon Therapeutics has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Parthenon Therapeutics?
Northpond Ventures, Pfizer Ventures, Taiho Ventures are named among the investors backing Parthenon Therapeutics.
What was the latest Parthenon Therapeutics funding round?
The most recent disclosed round is a Series A, announced in July 2024.
Where is Parthenon Therapeutics based?
Parthenon Therapeutics is based in San Francisco, CA.
When did Parthenon Therapeutics last raise?
The last disclosed Parthenon Therapeutics round closed in July 2024 at Series A.
We update the Parthenon Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in San Francisco and their backers are listed below.
